Description
An inhibitor of glucosylceramide synthase; inhibits glucosylceramide synthase by 70, 41, and 62% in MDCK cell homogenates, mouse liver microsomes, and mouse brain homogenates, respectively, at 20 µM; inhibits sphingomyelin synthase activity in P. falciparum-infected erythrocytes and inhibits growth of P. falciparum (IC50 = 0.85 µM)
Formal name: rel-N-[(1R,2R)-2-hydroxy-1-(4-morpholinylmethyl)-2-phenylethyl]-hexadecanamide, monohydrochloride
Synonyms: DL-threo-1-Phenyl-2-palmitoylamino-3-morpholino-1-propanol
Molecular weight: 511.2
CAS: 139974-41-7
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antiparasitics|Antiprotozoals||Product Type|Biochemicals|Small Molecule Inhibitors|Sphingolipid Turnover||Research Area|Cell Biology|Endomembrane System & Vesicular Trafficking|Autophagy||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Parasitic Diseases|Malaria||Research Area|Lipid Biochemistry|Sphingolipids||Research Area|Neuroscience